{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:59:10Z","timestamp":1790405950122,"version":"4.1.0"},"reference-count":27,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gen and Family Med"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Talaromyces marneffei<\/jats:italic>\n                      (TM) is an opportunistic infectious fungus, and more patients in HIV\u2010negative populations are infected with TM.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We reviewed the adult patients with\n                      <jats:styled-content style=\"fixed-case\">TM<\/jats:styled-content>\n                      infections (\n                      <jats:styled-content style=\"fixed-case\">TMIs<\/jats:styled-content>\n                      ) between November 1, 2020 and April 30, 2025. This single\u2010center retrospective study was conducted at a tertiary care hospital located in an urban area, eastern China. Patients with\n                      <jats:styled-content style=\"fixed-case\">TMI<\/jats:styled-content>\n                      were divided into the following four groups: the\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      group, the non\u2010\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      with solid organ transplant (\n                      <jats:styled-content style=\"fixed-case\">SOT<\/jats:styled-content>\n                      ) group, the non\u2010\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      with stem cell transplantation (\n                      <jats:styled-content style=\"fixed-case\">SCT<\/jats:styled-content>\n                      ) group, and the non\u2010\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      with other factors group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were a total of 218 cases of talaromycosis: 165 in the HIV group, 16 in the non\u2010HIV with SOT group, 4 in the non\u2010HIV with SCT group, and 33 in the non\u2010HIV with other factors group. The number (proportion) of patients diagnosed through metagenomic next\u2010generation sequencing (mNGS) in the four groups was as follows: 51 (30.9%), 11 (68.8%), 2 (50.0%), and 25 (75.8%), respectively. The number (proportion) of patients who tested positive in both culture and mNGS was as follows: 19 (11.5%), 1 (6.3%), 0 (0.0%), and 1 (3.0%), respectively. Kaplan\u2013Meier estimates indicated that the patients in the non\u2010HIV with SCT group had the worst prognosis and those in the non\u2010HIV with other factors group had poorer prognosis than the patients in the HIV group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TMI in patients who are HIV\u2010negative without SOT may have poorer prognosis. If talaromycosis is suspected, mNGS can be an important supplementary tool for confirming TMI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jgf2.70171","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:56:54Z","timestamp":1788778614000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognosis of Patients Infected With\n                    <i>Talaromyces marneffei<\/i>\n                    Across Various Risk Factors"],"prefix":"10.1002","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9062-3097","authenticated-orcid":false,"given":"JiaXin","family":"Wang","sequence":"first","affiliation":[{"name":"Kidney Disease Center, the First Affiliated Hospital, College of Medicine Zhejiang University  Hangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YaoMin","family":"Wang","sequence":"additional","affiliation":[{"name":"Kidney Disease Center, the First Affiliated Hospital, College of Medicine Zhejiang University  Hangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2063-8533","authenticated-orcid":false,"given":"RenDing","family":"Wang","sequence":"additional","affiliation":[{"name":"Kidney Disease Center, the First Affiliated Hospital, College of Medicine Zhejiang University  Hangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"issue":"2","key":"e_1_2_9_2_1","first-page":"200","article-title":"Talaromyces marneffei Infection: Virulence, Intracellular Lifestyle and Host Defense Mechanisms","volume":"8","author":"Pruksaphon K.","year":"2022","journal-title":"Journal of Fungi (Basel, Switzerland)"},{"key":"e_1_2_9_3_1","unstructured":"United States Department of Health and Human Services \u201cTalaromycosis (Penicilliosis) Guidelines [EB\/OL] \u201d(2025) https:\/\/Clinicalinfo.hiv.gov."},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/60.2.259"},{"issue":"4","key":"e_1_2_9_5_1","first-page":"1045","article-title":"Clinical Characteristics and Mortality Predictors of HIV\u2010Associated Talaromycosis Across Endemic Southeast Asia: A Multicenter Cohort Study","volume":"81","author":"Cao C.","year":"2025","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"e_1_2_9_6_1","article-title":"Talaromycosis in Non\u2010HIV Immunocompromised Patients: A Systematic Review and Meta\u2010Analysis","volume":"37","author":"Hu Y.","year":"2024","journal-title":"Clinical Microbiology Reviews"},{"issue":"3","key":"e_1_2_9_7_1","article-title":"Talaromyces (Penicillium) Marneffei Infection in Non\u2010HIV\u2010Infected Patients","volume":"5","author":"Chan J. F.","year":"2016","journal-title":"Emerging Microbes & Infections"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190502"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1243-y"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.5847\/wjem.j.1920-8642.2021.04.005"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13295"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-023-00801-5"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-021-01679-6"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.841674"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2023.04.398"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myae094"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1613306"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00191-2"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-012-9577-0"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2012.01.008"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12186"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-464"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-224"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094496"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1579522"},{"key":"e_1_2_9_26_1","article-title":"Diagnosis and Clinical Phenotypes of Talaromyces marneffei Infection in the mNGS Era","volume":"16","author":"Chan J. F.","year":"2026","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2111003"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012418-012751"}],"container-title":["Journal of General and Family Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jgf2.70171","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jgf2.70171","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jgf2.70171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:22:25Z","timestamp":1790403745000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jgf2.70171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1002\/jgf2.70171"],"URL":"https:\/\/doi.org\/10.1002\/jgf2.70171","archive":["Portico"],"relation":{},"ISSN":["2189-7948","2189-7948"],"issn-type":[{"value":"2189-7948","type":"print"},{"value":"2189-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"2026-02-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70171"}}